Share and Corporate Information

Share and Corporate Information

Share Information

Date of Listing 8 / 11 / 2017
Number of Listed Shares 722,000,000
Par Value / Share 0.25 EGP (twenty five piasters)
Authorized Capital 1,000,000,000 EGP (one billion Egyptian Pounds) 
Issued Capital 180,500,000 EGP (one hundred eighty million and five hundred thousand Egyptian Pounds)
Paid-Up Capital 180,500,000 EGP (one hundred eighty million and five hundred thousand Egyptian Pounds)

Shareholder Structure

Ibnsina Pharma’s shareholders include prominent members of the Egyptian business community and large institutional shareholders that have allowed the company to significantly enhance its corporate governance practices and systems.  The company’s shareholders include the Mahgoub family (16.2%), the Abdel Gawad family (16.5%), the European Bank for Reconstruction and Development (EBRD) (10.1%), and Faisal Islamic Bank (12.6%). Other shareholders, including members of its senior management team, collectively (7.2%), and free float (37.4%).


Corporate Information

Year Founded 2001
Commercial Registration Number Commercial Registration number 10724 dated 28/8/2017 Commercial Registry Office, Cairo
Fiscal Year 1 January - 31 December
Law of Governance Law (159) 1981
Auditor Name Khaled El-Ghannam & Co.
  Deliotte - Saleh, Barsoum & Abdel Aziz
Headquarters Obour City, Industrial Zone 1, Block 12015, Egypt